Near-Infrared dyes: Probe development and applications in optical molecular imaging

Current Organic Synthesis

Volumn 8, Issue 4, 2011, Pages 521-534

  Nolting, Donald D ^a   Gore, John C ^a   Pham, Wellington ^a  

^a VANDERBILT UNIVERSITY   (United States)

Author keywords

Cyanine; Fluorescence; FRET; Imaging; Optical; Probe; Rhodamine

Indexed keywords

EID: 79959948213     PISSN: 15701794     EISSN: None     Source Type: Journal    
DOI: 10.2174/157017911796117223     Document Type: Review

References (88)

1. Pham, W.; Choi, Y.; Weissleder, R.; Tung, C. H. Developing a peptide-basednear-infrared molecular probe for protease sensing. Bioconjug. Chem. 2004,15(6), 1403-1407.
2. Raymond, S.B.; Skoch, J.; Hills, I.D.; Nesterov, E.E.; Swager, T.M.; Bacskai, B.J. Smart optical probes for near-infrared fluorescence imaging ofAlzheimer's disease pathology. Eur. J. Nucl. Med. Mol. Imag. 2008, 35 Suppl 1, S93-98.
3. Haugland, R.B. Handbook of Fluorescent Probes. Mol. Probes Inc. 1996.
4. Fabian, J.; Nakazumi, H.; Matsuoka, M. Near-infrared absorbing dyes. Chem. Rev. (Washington, DC, United States) 1992, 92(6), 1197-1226.
5. Spiliadis, A.; Vladutiu, L.; Zaharia, M. A study concering Fischer aldehydecondensation with aromatic amines. Rev. Chim. (Buc.) 1975, 26(11), 868-901.
6. Gaspar, C. L.; Baldea, I.; Panea, I. Kinetics of the formation of hemicyaninedyes by the condensation of Fischer's base aldehyde with anilines. DyesPigments 2006, 69, 45-53.
7. Fluhler, E.; Burnham, V. G.; Loew, L. M. Spectra, membrane binding,and potentiometric responses of new charge shift probes. Biochemistry 1985,24(21), 5749-5755;
8. Fromherz, P.; Mueller, C.O. Voltage-sensitivefluorescence of amphiphilic hemicyanine dyes in neuron membrane. Biochim. Biophys. Acta 1993, 1150, 111-122;
9. Grinvald, A.; Hildesheim, R.; Farber, I. C.; Anglister, L. Improved fluorescent probes for themeasurement of rapid changes in membrane potential. Biophys. J. 1982,39(3), 301-308.
10. Konig, W. Ber. Dtsch. Chem. Ges. B 1922, 55B, 3293.
11. Konig, W. Angew. Chem. 1925, 743.
12. Mujumdar, R. B.; Ernst, L. A.; Mujumdar, S. R.; Lewis, C. J.; Waggoner, A.S. Cyanine dye labeling reagents: sulfoindocyanine succinimidyl esters. Bioconjug. Chem. 1993, 4(2), 105-11.
13. Dyadyusha, G. G.; Kachkovskii, A. D.; Dekhtyar, M. L. Perturbation theoryof nonbonding orbitals in polymeric dyes. Theor. Exp. Chem. 1987, 24,251-256.
14. Pham, W.; Weissleder, R.; Tung, C.-H. An azulene dimer as a nearinfraredquencher. Angew. Chem., Int. Ed. 2002, 41(19), 3659-3662;
15. Pham, W.; Lai, W. F.; Weissleder, R.; Tung, C. H. High efficiency synthesisof a bioconjugatable near-infrared fluorochrome. Bioconjug. Chem. 2003,14(5), 1048-1051.
16. Reynolds, G. A.; Drexhage, K. H. Stable heptamethine pyrylium dyes thatabsorb in the infrared. J. Org. Chem. 1977, 42(5), 885-888.
17. Mujumdar, S. R.; Mujumdar, R. B.; Grant, C. M.; Waggoner, A. S. Cyaninelabelingreagents: sulfobenzindocyanine succinimidyl esters. Bioconjug.Chem. 1996, 7(3), 356-362.
18. Pham, W.; Medarova, Z.; Moore, A. Synthesis and application of a watersolublenear-infrared dye for cancer detection using optical imaging. Bioconjug. Chem. 2005, 16(3), 735-740.
19. Shao, F.; Weissleder, R.; Hilderbrand, S. A. Monofunctional carbocyaninedyes for bio- and bioorthogonal conjugation. Bioconjugate Chem. 2008,19(12), 2487-2491.
20. Pham, W.; Cassell, L.; Gillman, A.; Koktysh, D.; Gore, J. C. A near-infrareddye for multichannel imaging. Chem. Commun. (Camb.) 2008, (16), 1895-1897.
21. Kiyose, K.; Kojima, H.; Urano, Y.; Nagano, T. Development of aratiometric fluorescent zinc ion probe in near-infrared region, based ontricarbocyanine chromophore. J. Am. Chem. Soc. 2006, 128 (20), 6548-9;
22. Peng, X.; Song, F.; Lu, E.; Wang, Y.; Zhou, W.; Fan, J.; Gao, Y. Heptamethine cyanine dyes with a large stokes shift and strong fluorescence:a paradigm for excited-state intramolecular charge transfer. J. Am. Chem.Soc. 2005, 127(12), 4170-4171.
23. Kulinich, A. V.; Ishchenko, A. A. Merocyanine Dyes: Synthesis, structure,properties and applications. Russ. Chem. Rev. 2009, 78(2), 141-164.
24. Berkovic, G.; Krongauz, V.; Weiss, V. Spiropyrans and Spirooxazines for Memories and Switches. Chem. Rev. 2000, 100(5), 1741-1754.
25. Shen, Q.; Cao, Y.; Liu, S.; Steigerwald, M. L.; Guo, X. F. Conformationinducedelectrostatic gating of teh conduction of spiropyran-coated organicthin-film transitors. J. Phys. Chem. 2009, 113(24), 10807-10812.
26. Horiuchi, T.; Miura, H.; Uchida, S. Highly-efficient metal-free organic dyesfor dye-sensitized solar cells. Chem. Commun. (Camb.) 2003, (24), 3036-3037.
27. Bossi, M.; Belov, V.; Polyakova, S.; Hell, S. W. Reversible red fluorescentmolecular switches. Angew. Chem. Int. Ed. Engl. 2006, 45(44), 7462-7465.
28. Drexhage, K. H. J. Res. Natl. Bur. Stand. 1976, 80A, 421-428.
29. Beija, M.; Afonso, C. A.; Martinho, J. M. Synthesis and applications ofRhodamine derivatives as fluorescent probes. Chem. Soc. Rev. 2009, 38(8),2410-2433.
30. Chandran, S. S.; Dickson, K. A.; Raines, R. T. Latent fluorophore based onthe trimethyl lock. J. Am. Chem. Soc. 2005, 127(6), 1652-1653.
31. Milstein, S.; Cohen, L. A. J. Am. Chem. Soc. 1972, 94, 9158-9165.
32. Riggs, J. L.; Seiwald, R. J.; Burckhalter, J. H.; Downs, C. M.; Metcalf, T. G.Isothiocyanate compounds as fluorescent labeling agents for immune serum.Am. J. Pathol. 1958, 34(6), 1081-1097.
33. Lefevre, C.; Kang, H. C.; Haugland, R. P.; Malekzadeh, N.; Arttamangkul, S.; Haugland, R. P. Texas Red-X and Rhodamine Red-X, New Derivatives ofSulforhodamine 101 and Lissamine Rhodamine B with Improved Labelingand Fluorescence Properties. Bioconjug. Chem. 1996, 7(4), 482-489.
34. Lieberwirth, U.; Arden-Jacob, J.; Drexhage, K. H.; Herten, D. P.; Muller, R.; Neumann, M.; Schulz, A.; Siebert, S.; Sagner, G.; Klingel, S.; Sauer, M.; Wolfrum, J. Multiplex dye DNA sequencing in capillary gel electrophoresisby diode laser-based time-resolved fluorescence detection. Anal. Chem.1998, 70(22), 4771-9.
35. Alford, R.; Ogawa, M.; Choyke, P. L.; Kobayashi, H. Molecular probes forthe in vivo imaging of cancer. Mol. Biosyst. 2009, 5(11), 1279-1291.
36. Lecchi, M.; Ottobrini, L.; Martelli, C.; Del Sole, A.; Lucignani, G. Instrumentation and probes for molecular and cellular imaging. Q J. Nucl.Med. Mol. Imag. 2007, 51 (2), 111-26.
37. Lee, S.; Park, K.; Kim, K.; Choi, K.; Kwon, I.C. Activatable imaging probeswith amplified fluorescent signals. Chem. Commun. (Camb.) 2008, (36),4250-4260.
38. Rao, J.; Dragulescu-Andrasi, A.; Yao, H. Fluorescence imaging in vivo: recent advances. Curr. Opin. Biotech. 2007, 18 (1), 17-25.
39. Kiyose, K.; Kojima, H.; Nagano, T. Functional near-infrared fluorescentprobes. Chem. Asian. J. 2008, 3, 506-515.
40. Bloch, S.; Lesage, F.; McIntosh, L.; Gandjbakhche, A.; Liang, K.; Achilefu, S. Whole-body fluorescence lifetime imaging of a tumor-targeted nearinfraredmolecular probe in mice. J. Biomed. Opt. 2005, 10(5), 054003.
41. Rasmussen, J. C.; Tan, I. C.; Marshall, M. V.; Fife, C. E.; Sevick-Muraca, E.M. Lymphatic imaging in humans with near-infrared fluorescence. Curr.Opin. Biotechnol. 2009, 20(1), 74-82.
42. Bugaj, J. E.; Achilefu, S.; Dorshow, R. B.; Rajagopalan, R. Novelfluorescent contrast agents for optical imaging of in vivo tumors based on areceptor-targeted dye-peptide conjugate platform. J. Biomed. Opt. 2001, 6(2),122-133.
43. Bremer, C.; Ntziachristos, V.; Weissleder, R. Optical-based molecularimaging: contrast agents and potential medical applications. Eur. Radiol.2003, 13(2), 231-243.
44. Hilderbrand, S. A.; Weissleder, R. Near-infrared fluorescence: application toin vivo molecular imaging. Curr. Opin. Chem. Biol. 2010, 14(1), 71-79.
45. Moon, W. K.; Lin, Y.; O'Loughlin, T.; Tang, Y.; Kim, D. E.; Weissleder, R.; Tung, C. H. Enhanced tumor detection using a folate receptor-targeted nearinfraredfluorochrome conjugate. Bioconjug. Chem. 2003, 14(3), 539-545.
46. Li, C.; Greenwood, T. R.; Glunde, K. Glucosamine-bound near-infraredfluorescent probes with lysosomal specificity for breast tumor imaging. Neoplasia 2008, 10(4), 389-398.
47. Li, C.; Greenwood, T. R.; Bhujwalla, Z. M.; Glunde, K. Synthesis andcharacterization of glucosamine-bound near-infrared probes for opticalimaging. Org. Lett. 2006, 8(17), 3623-3626.
48. Ye, Y.; Bloch, S.; Xu, B.; Achilefu, S. Design, synthesis, and evaluation ofnear infrared fluorescent multimeric RGD peptides for targeting tumors. J.Med. Chem. 2006, 49(7), 2268-2275.
49. Kelly, K. A.; Carson, J.; McCarthy, J. R.; Weissleder, R. Novel peptidesequence (IQ-tag) with high affinity for NIR fluorochromes allows proteinand cell specific labeling for in vivo imaging. PLoS One 2007, 2(7), e665.
50. Kosaka, N.; Ogawa, M.; Choyke, P. L.; Karassina, N.; Corona, C.; McDougall, M.; Lynch, D. T.; Hoyt, C. C.; Levenson, R. M.; Los, G. V.; Kobayashi, H. In vivo stable tumor-specific painting in various colors usingdehalogenase-based protein-tag fluorescent ligands. Bioconjug. Chem. 2009,20(7), 1367-1374.
51. Schellenberger, E. A.; Bogdanov, A. Jr.; Petrovsky, A.; Ntziachristos, V.; Weissleder, R.; Josephson, L. Optical imaging of apoptosis as a biomarker oftumor response to chemotherapy. Neoplasia 2003, 5(3), 187-192.
52. Ntziachristos, V.; Schellenberger, E. A.; Ripoll, J.; Yessayan, D.; Graves, E.; Bogdanov, A., Jr.; Josephson, L.; Weissleder, R. Visualization of antitumortreatment by means of fluorescence molecular tomography with an annexinV-Cy5.5 conjugate. Proc. Natl. Acad. Sci. USA 2004, 101(33), 12294-12299.
53. Shah, C.; Miller, T. W.; Wyatt, S. K.; McKinley, E. T.; Olivares, M. G.; Sanchez, V.; Nolting, D. D.; Buck, J. R.; Zhao, P.; Ansari, M. S.; Baldwin, R.M.; Gore, J. C.; Schiff, R.; Arteaga, C. L.; Manning, H.C. Imagingbiomarkers predict response to anti-HER2 (ErbB2) therapy in preclinicalmodels of breast cancer. Clin. Cancer. Res. 2009, 15(14), 4712-4721.
54. Pham, W.; Xie, J.; Gore, J. C. Tracking the migration of dendritic cells by invivo optical imaging. Neoplasia 2007, 9(12), 1130-1137.
55. Pham, W.; Zhao, B. Q.; Lo, E. H.; Medarova, Z.; Rosen, B.; Moore, A. Crossing the blood-brain barrier: a potential application of myristoylatedpolyarginine for in vivo neuroimaging. Neuroimage 2005, 28(1), 287-292.
56. Kobayashi, H.; Koyama, Y.; Barrett, T.; Hama, Y.; Regino, C. A.; Shin, I. S.; Jang, B. S.; Le, N.; Paik, C. H.; Choyke, P. L.; Urano, Y. Multimodalnanoprobes for radionuclide and five-color near-infrared optical lymphaticimaging. ACS Nano 2007, 1(4), 258-264.
57. Leevy, W. M.; Gammon, S. T.; Jiang, H.; Johnson, J. R.; Maxwell, D. J.; Jackson, E. N.; Marquez, M.; Piwnica-Worms, D.; Smith, B. D. Opticalimaging of bacterial infection in living mice using a fluorescent near-infraredmolecular probe. J. Am. Chem. Soc. 2006, 128(51), 16476-16477.
58. Leevy, W. M.; Gammon, S. T.; Johnson, J. R.; Lampkins, A. J.; Jiang, H.; Marquez, M.; Piwnica-Worms, D.; Suckow, M. A.; Smith, B.D. Noninvasive optical imaging of staphylococcus aureus bacterial infection inliving mice using a Bis-dipicolylamine-Zinc(II) affinity group conjugated toa near-infrared fluorophore. Bioconjug. Chem. 2008, 19(3), 686-692.
59. Urano, Y.; Kamiya, M.; Kanda, K.; Ueno, T.; Hirose, K.; Nagano, T. Evolution of fluorescein as a platform for finely tunable fluorescence probes. J. Am. Chem. Soc. 2005, 127(13), 4888-4894.
60. Nesterov, E. E.; Skoch, J.; Hyman, B. T.; Klunk, W. E.; Bacskai, B. J.; Swager, T. M. In vivo optical imaging of amyloid aggregates in brain: designof fluorescent markers. Angew. Chem. Int. Ed. Engl. 2005, 44(34), 5452-5456.
61. Ran, C.; Xu, X.; Raymond, S. B.; Ferrara, B. J.; Neal, K.; Bacskai, B. J.;Medarova, Z.; Moore, A. Design, synthesis, and testing of difluoroboronderivatizedcurcumins as near-infrared probes for in vivo detection ofamyloid-beta deposits. J. Am. Chem. Soc. 2009, 131(42), 15257-15261.
62. Pham, W.; Pantazopoulos, P.; Moore, A. Imaging farnesyl protein transferaseusing a topologically activated probe. J. Am. Chem. Soc. 2006, 128(36),11736-1177.
63. Sapsford, K. E.; Berti, L.; Medintz, I. L. Materials for fluorescenceresonance energy transfer analysis: beyond traditional donor-acceptorcombinations. Angew. Chem. Int. Ed. 2006, 45(28), 4562-4589.
64. Pham, W.; Weissleder, R.; Tung, C. H. An azulene dimer as a near-infraredquencher. Angew. Chem. Int. Ed. Engl. 2002, 41 (19), 3659-62, 3519.
65. Jiang, T.; Olson, E. S.; Nguyen, Q. T.; Roy, M.; Jennings, P. A.; Tsien, R. Y.Tumor imaging by means of proteolytic activation of cell-penetratingpeptides. Proc. Natl. Acad. Sci. USA 2004, 101 (51), 17867-72.
66. Bullok, K. E.; Gammon, S. T.; Violini, S.; Prantner, A. M.; Villalobos, V.M.; Sharma, V.; Piwnica-Worms, D. Permeation peptide conjugates for invivo molecular imaging applications. Mol. Imag. 2006, 5(1), 1-15.
67. Bullok, K.; Piwnica-Worms, D. Synthesis and characterization of a small,membrane-permeant, caspase-activatable far-red fluorescent peptide forimaging apoptosis. J. Med. Chem. 2005, 48(17), 5404-5407.
68. Bullok, K. E.; Maxwell, D.; Kesarwala, A. H.; Gammon, S.; Prior, J. L.; Snow, M.; Stanley, S.; Piwnica-Worms, D. Biochemical and in vivocharacterization of a small, membrane-permeant, caspase-activatable far-redfluorescent peptide for imaging apoptosis. Biochemistry 2007, 46(13), 4055-4065.
69. Maxwell, D.; Chang, Q.; Zhang, X.; Barnett, E. M.; Piwnica-Worms, D. Animproved cell-penetrating, caspase-activatable, near-infrared fluorescentpeptide for apoptosis imaging. Bioconjug. Chem. 2009, 20(4), 702-709.
70. Blum, G.; Mullins, S. R.; Keren, K.; Fonovic, M.; Jedeszko, C.; Rice, M. J.; Sloane, B. F.; Bogyo, M. Dynamic imaging of protease activity withfluorescently quenched activity-based probes. Nat. Chem. Biol. 2005, 1(4),203-209.
71. Blum, G.; von Degenfeld, G.; Merchant, M. J.; Blau, H. M.; Bogyo, M. Noninvasive optical imaging of cysteine protease activity using fluorescentlyquenched activity-based probes. Nat. Chem. Biol. 2007, 3(10), 668-677.
72. Bao, G.; Rhee, W. J.; Tsourkas, A. Fluorescent probes for live-cell RNAdetection. Annu. Rev. Biomed. Eng. 2009, 11, 25-47.
73. Tyagi, S.; Kramer, F. R. Molecular beacons: probes that fluoresce uponhybridization. Nat. Biotechnol. 1996, 14(3), 303-308.
74. Law, B.; Curino, A.; Bugge, T. H.; Weissleder, R.; Tung, C. H. Design,synthesis, and characterization of urokinase plasminogen-activator-sensitivenear-infrared reporter. Chem. Biol. 2004, 11(1), 99-106.
75. Law, B.; Weissleder, R.; Tung, C. H. Protease-sensitive fluorescentnanofibers. Bioconjug. Chem. 2007, 18(6), 1701-1704.
76. Galande, A. K.; Hilderbrand, S. A.; Weissleder, R.; Tung, C. H. Enzymetargetedfluorescent imaging probes on a multiple antigenic peptide core. J.Med. Chem. 2006, 49(15), 4715-4120.
77. Wunderbaldinger, P.; Turetschek, K.; Bremer, C. Near-infrared fluorescenceimaging of lymph nodes using a new enzyme sensing activatablemacromolecular optical probe. Eur. Radiol. 2003, 13(9), 2206-2211.
78. Kim, K.; Lee, M.; Park, H.; Kim, J. H.; Kim, S.; Chung, H.; Choi, K.; Kim, I.S.; Seong, B. L.; Kwon, I. C. Cell-permeable and biocompatible polymericnanoparticles for apoptosis imaging. J. Am. Chem. Soc. 2006, 128(11), 3490-3491.
79. McIntyre, J. O.; Fingleton, B.; Wells, K. S.; Piston, D. W.; Lynch, C. C.; Gautam, S.; Matrisian, L. M. Development of a novel fluorogenic proteolyticbeacon for in vivo detection and imaging of tumour-associated matrixmetalloproteinase-7 activity. Biochem. J. 2004, 377(Pt 3), 617-628.
80. Scherer, R. L.; VanSaun, M. N.; McIntyre, J. O.; Matrisian, L. M. Opticalimaging of matrix metalloproteinase-7 activity in vivo using a proteolyticnanobeacon. Mol. Imag. 2008, 7(3), 118-131.
81. Ogawa, M.; Kosaka, N.; Longmire, M. R.; Urano, Y.; Choyke, P. L.; Kobayashi, H. Fluorophore-Quencher Based Activatable Targeted OpticalProbes for Detecting in Vivo Cancer Metastases. Mol. Pharm. 2009, 6(2),386-395.
82. Ogawa, M.; Regino, C. A.; Choyke, P. L.; Kobayashi, H. In vivo targetspecificactivatable near-infrared optical labeling of humanized monoclonalantibodies. Mol. Cancer. Ther. 2009, 8(1), 232-239.
83. Sampath, L.; Kwon, S.; Ke, S.; Wang, W.; Schiff, R.; Mawad, M. E.; Sevick-Muraca, E. M. Dual-labeled trastuzumab-based imaging agent for thedetection of human epidermal growth factor receptor 2 overexpression inbreast cancer. J. Nucl. Med. 2007, 48(9), 1501-1510.
84. Houston, J. P.; Ke, S.; Wang, W.; Li, C.; Sevick-Muraca, E. M. Qualityanalysis of in vivo near-infrared fluorescence and conventional gammaimages acquired using a dual-labeled tumor-targeting probe. J. Biomed. Opt.2005, 10(5), 054010.
85. Wang, W.; Ke, S.; Kwon, S.; Yallampalli, S.; Cameron, A. G.; Adams, K. E.; Mawad, M. E.; Sevick-Muraca, E. M. A new optical and nuclear duallabeledimaging agent targeting interleukin 11 receptor alpha-chain. Bioconjug. Chem. 2007, 18(2), 397-402.
86. Kircher, M. F.; Mahmood, U.; King, R. S.; Weissleder, R.; Josephson, L. Amultimodal nanoparticle for preoperative magnetic resonance imaging andintraoperative optical brain tumor delineation. Cancer. Res. 2003, 63(23),8122-8125.
87. Schellenberger, E. A.; Sosnovik, D.; Weissleder, R.; Josephson, L.Magneto/optical annexin V, a multimodal protein. Bioconjug. Chem. 2004,15(5), 1062-1067.
88. Medarova, Z.; Pham, W.; Farrar, C.; Petkova, V.; Moore, A. In vivo imaging of siRNA delivery and silencing in tumors. Nat. Med. 2007, 13(3), 372-377.